ArticleJournal of cellular and molecular medicine2017

miR-495 sensitizes MDR cancer cells to the combination of doxorubicin and taxol by inhibiting MDR1 expression.

Zhenyou Zou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.